Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Serum Levels of ARMS2, COL8A1, RAD51B, and VEGF and their Correlations in Age-related Macular Degeneration

Author(s): Priya Battu, Kaushal Sharma, Manjari Rain, Ramandeep Singh and Akshay Anand*

Volume 18, Issue 2, 2021

Published on: 31 May, 2021

Page: [181 - 188] Pages: 8

DOI: 10.2174/1567202618666210531130711

Price: $65

Abstract

Background: Many factors including genetic and environmental are responsible for the incidence of Age-related Macular Degeneration (AMD). However, its pathogenesis has not been clearly elucidated yet.

Objective: This study aimed to estimate the Age-Related Maculopathy Susceptibility 2 (ARMS2), Collagen type VIII Alpha 1 chain (COL8A1), Rad 51 paralog(RAD51B), and Vascular Endothelial Growth Factor (VEGF) protein levels in serum of AMD and control participants and to further investigate their correlation to understand AMD pathogenesis.

Methods: For this case-control study, 31 healthy control and 57 AMD patients were recruited from Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India. A blood sample was taken and serum was isolated from it. ELISA (enzyme-linked immunosorbent assay) was used for the estimation of proteins in the serum of patients.

Results: ARMS2 and COL8A1 levels were significantly elevated in the AMD group than in the control group. The highest levels of ARMS2, COL8A1, and VEGF proteins were recorded for the wet AMD sub-group. The study results endorsed significant positive correlation between these following molecules; ARMS2 and COL8A1 (r = 0.933, p < 0.0001), ARMS2 and RAD51B (r = 0.704, p < 0.0001), ARMS2 and VEGF (r = 0.925, p < 0.0001), COL8A1 and RAD51B (r = 0.736, p < 0.0001), COL8A1 and VEGF (r = 0.879, p < 0.0001), and RAD51B and VEGF (r = 0.691, p < 0.0001).

Conclusion: The ARMS2 and COL8A1 levels were significantly higher and RAD51B was significantly lower in the AMD group than controls. Also, a significant statistical correlation was detected between these molecules, indicating that their interaction may be involved in the pathogenesis of AMD.

Keywords: Age-related macular degeneration, ARMS2, COL8A1, RAD51B, VEGF, ELISA.

« Previous Next »
[1]
de Jong EK, Geerlings MJ, den Hollander AI. Age-related macular degeneration. In: In: Genetics and Genomics of Eye Disease. Elsevier 2020; pp. 155-80.
[http://dx.doi.org/10.1016/B978-0-12-816222-4.00010-1]
[2]
García-Onrubia L, Valentín-Bravo FJ, Coco-Martin RM, et al. Matrix metalloproteinases in age-related macular degeneration (AMD). Int J Mol Sci 2020; 21(16): 5934.
[http://dx.doi.org/10.3390/ijms21165934] [PMID: 32824762]
[3]
Fritsche LG, Igl W, Bailey JNC, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 2016; 48(2): 134-43.
[http://dx.doi.org/10.1038/ng.3448] [PMID: 26691988]
[4]
Shin H-T, Yoon BW, Seo JH. Comparison of risk allele frequencies of single nucleotide polymorphisms associated with age-related macular degeneration in different ethnic groups. BMC Ophthalmol 2021; 21(1): 97.
[http://dx.doi.org/10.1186/s12886-021-01830-9] [PMID: 33618707]
[5]
Cascella R, Strafella C, Longo G, et al. Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants. Oncotarget 2017; 9(8): 7812-21.
[http://dx.doi.org/10.18632/oncotarget.23241] [PMID: 29487693]
[6]
Sharma K, Sharma NK, Singh R, Sharma SK, Anand A. Gene networks determine predisposition to AMD. Genomics 2021; 113(1 Pt 2): 514-22.
[http://dx.doi.org/10.1016/j.ygeno.2020.09.044] [PMID: 32979492]
[7]
Sundaresan P, Vashist P, Ravindran RD, et al. Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study. Invest Ophthalmol Vis Sci 2012; 53(12): 7492-7.
[http://dx.doi.org/10.1167/iovs.12-10073] [PMID: 23060141]
[8]
van Asten F, Simmons M, Singhal A, et al. A deep phenotype association study reveals specific phenotype associations with genetic variants in age-related macular degeneration: Age-related eye disease study 2 (AREDS2) report no. 14. Ophthalmology 2018; 125(4): 559-68.
[http://dx.doi.org/10.1016/j.ophtha.2017.09.023] [PMID: 29096998]
[9]
Micklisch S, Lin Y, Jacob S, et al. Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator. J Neuroinflammation 2017; 14(1): 4.
[http://dx.doi.org/10.1186/s12974-016-0776-3] [PMID: 28086806]
[10]
Hopfer U, Fukai N, Hopfer H, et al. Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J 2005; 19(10): 1232-44.
[http://dx.doi.org/10.1096/fj.04-3019com] [PMID: 16051690]
[11]
Takata M, Sasaki MS, Sonoda E, et al. The Rad51 paralog Rad51B promotes homologous recombinational repair. Mol Cell Biol 2000; 20(17): 6476-82.
[http://dx.doi.org/10.1128/MCB.20.17.6476-6482.2000] [PMID: 10938124]
[12]
Albala JS, Thelen MP, Prange C, et al. Identification of a novel human RAD51 homolog, RAD51B. Genomics 1997; 46(3): 476-9.
[http://dx.doi.org/10.1006/geno.1997.5062] [PMID: 9441753]
[13]
Seddon JM, Reynolds R, Yu Y, Rosner B. Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One 2014; 9(1): e87047.
[http://dx.doi.org/10.1371/journal.pone.0087047] [PMID: 24498017]
[14]
Ferrara N. The role of the vegf signaling pathway in tumor angiogenesis. Tumor angiogenesis: A key target for cancer therapy. Expert Rev Anticancer Ther 2019; 18(3): 251-66.
[15]
Jin Y. Effect of intravitreal injection of anti-VEGF on choroidal thickness and blood flow in posterior ciliary artery in patients with wet ARMD. International Eye Science 2018; 18(12): 2244-7.
[16]
Pugazhendhi A, Hubbell M, Jairam P, Ambati B. Neovascular macular degeneration: A review of etiology, risk factors, and recent advances in research and therapy. Int J Mol Sci 2021; 22(3): 1170.
[http://dx.doi.org/10.3390/ijms22031170] [PMID: 33504013]
[17]
Keir LS, Firth R, Aponik L, et al. VEGF regulates local inhibitory complement proteins in the eye and kidney. J Clin Invest 2017; 127(1): 199-214.
[http://dx.doi.org/10.1172/JCI86418] [PMID: 27918307]
[18]
Foxton RH, Uhles S, Grüner S, Revelant F, Ullmer C. Efficacy of simultaneous VEGF-A/ANG-2 neutralization in suppressing spontaneous choroidal neovascularization. EMBO Mol Med 2019; 11(5): e10204.
[http://dx.doi.org/10.15252/emmm.201810204] [PMID: 31040126]
[19]
McKibbin M, Ali M, Bansal S, et al. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Br J Ophthalmol 2012; 96(2): 208-12.
[http://dx.doi.org/10.1136/bjo.2010.193680] [PMID: 21558292]
[20]
Corominas J, Colijn JM, Geerlings MJ, et al. Whole-exome sequencing in age-related macular degeneration identifies rare variants in COL8A1, a component of Bruch’s membrane. Ophthalmology 2018; 125(9): 1433-43.
[http://dx.doi.org/10.1016/j.ophtha.2018.03.040] [PMID: 29706360]
[21]
Ma Z-H, Ma J-H, Jia L, Zhao Y-F. Effect of enhanced expression of COL8A1 on lymphatic metastasis of hepatocellular carcinoma in mice. Exp Ther Med 2012; 4(4): 621-6.
[http://dx.doi.org/10.3892/etm.2012.652] [PMID: 23170115]
[22]
Imai H, Honda S, Kondo N, Ishibashi K, Tsukahara Y, Negi A. The upregulation of angiogenic gene expression in cultured retinal pigment epithelial cells grown on type I collagen. Curr Eye Res 2007; 32(10): 903-10.
[http://dx.doi.org/10.1080/02713680701604749] [PMID: 17963110]
[23]
Blasiak J, Pawlowska E, Sobczuk A, Szczepanska J, Kaarniranta K. The aging stress response and its implication for AMD pathogenesis. Int J Mol Sci 2020; 21(22): 8840.
[http://dx.doi.org/10.3390/ijms21228840] [PMID: 33266495]
[24]
Pires E, Sung P, Wiese C. Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis. DNA Repair (Amst) 2017; 59: 76-81.
[http://dx.doi.org/10.1016/j.dnarep.2017.09.008] [PMID: 28963981]
[25]
Kaplan AR, Gueble SE, Liu Y, et al. Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51. Sci Transl Med 2019; 11(492): eaav4508.
[http://dx.doi.org/10.1126/scitranslmed.aav4508] [PMID: 31092693]
[26]
Zhao W, Steinfeld JB, Liang F, et al. BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing. Nature 2017; 550(7676): 360-5.
[http://dx.doi.org/10.1038/nature24060] [PMID: 28976962]
[27]
Kang HJ, Kim HJ, Rih J-K, et al. BRCA1 plays a role in the hypoxic response by regulating HIF-1α stability and by modulating vascular endothelial growth factor expression. J Biol Chem 2006; 281(19): 13047-56.
[http://dx.doi.org/10.1074/jbc.M513033200] [PMID: 16543242]
[28]
Kawai H, Li H, Chun P, Avraham S, Avraham HK. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 2002; 21(50): 7730-9.
[http://dx.doi.org/10.1038/sj.onc.1205971] [PMID: 12400015]
[29]
Singh KK, Shukla PC, Quan A, et al. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis. J Thorac Cardiovasc Surg 2013; 146(4): 949-960.e4.
[http://dx.doi.org/10.1016/j.jtcvs.2012.12.064] [PMID: 23415688]
[30]
Guimaraes TAC, Georgiou M, Bainbridge JWB, Michaelides M. Gene therapy for neovascular age-related macular degeneration: Rationale, clinical trials and future directions. Br J Ophthalmol 2021; 105(2): 151-7.
[http://dx.doi.org/10.1136/bjophthalmol-2020-316195] [PMID: 32269060]

Rights & Permissions Print Cite
Article Metrics
29
1
© 2024 Bentham Science Publishers | Privacy Policy